Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-294869

Chief Legal Officer acquired 2,470 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SUMER JACQUELYN L · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-30 Grant or award : show line 1 in the form +2,470 $8.60 $21,242 130,559 D
Loading xslF345X06/ownership.xml…